Skip to main content
Print Save

Cabenuva Prices, Coupons and Patient Assistance Programs

Cabenuva (cabotegravir/rilpivirine) is a member of the antiviral combinations drug class and is commonly used for HIV Infection.

Cabenuva prices

The cost for Cabenuva intramuscular suspension, extended release (200 mg-300 mg/mL) is around $4,284 for a supply of 4 milliliters, depending on the pharmacy you visit. Prices are for cash paying customers only and are not valid with insurance plans.

This Cabenuva price guide is based on using the Drugs.com discount card which is accepted at most U.S. pharmacies.

Intramuscular Suspension, Extended Release

Drugs.com Printable Discount Card

The free Drugs.com Discount Card works like a coupon and can save you up to 80% or more off the cost of prescription medicines, over-the-counter drugs and pet prescriptions.

Print Free Discount Card

Please note: This is a drug discount program, not an insurance plan. Valid at all major chains including Walgreens, CVS Pharmacy, Target, WalMart Pharmacy, Duane Reade and 65,000 pharmacies nationwide.

Cabenuva Coupons and Rebates

Cabenuva offers may be in the form of a printable coupon, rebate, savings card, trial offer, or free samples. Some offers may be printed right from a website, others require registration, completing a questionnaire, or obtaining a sample from the doctor's office.

Cabenuva Savings Program: Eligible commercially insured patients pay $0 per prescription with savings of up to $13,000 per year; for additional information contact the program at 844-588-3288.

Applies to:
Cabenuva
Number of uses:
Per prescription per year

Form more information phone: 844-588-3288 or Visit website

Patient Assistance Programs for Cabenuva

Patient assistance programs (PAPs) are usually sponsored by pharmaceutical companies and provide free or discounted medicines to low income or uninsured and under-insured people who meet specific guidelines. Eligibility requirements vary for each program.

Provider: Patient Access Network Foundation (PAN)

Elligibility requirements:
  1. *See Additional Information section below
  2. Between 400-500% of FPL
  3. FDA Approved Diagnosis - See Program Website for Details
  4. Must reside and receive treatment in US
  5. *Patients must have health insurance and their insurance must cover the qualifying medication for which they seek assistance. Call for most recent medications as the list is subject to change and the medication for which you are seeking assistance must treat the disease directly. Note: All new enrollment is now done electronically or over the phone. Contact program for details.
Applicable drugs:
  • Cabenuva (cabotegravir and rilpivirine) Extended Release Injections for Suspension

More information please phone: 866-316-7263 Visit Website

Provider: Good Days Program

Elligibility requirements:
  1. Must have insurance
  2. At or below 500% of FPL
  3. FDA-approved diagnosis
  4. The patient must also be a US resident with a Social Security Number.
  5. Call for most recent medications as the list is subject to change and the medication for which you are seeking assistance must treat the disease directly.
Applicable drugs:
  • Cabenuva (cabotegravir and rilpivirine) Extended Release Injections for Suspension

More information please phone: 877-968-7233 Visit Website

Provider: ViiV Healthcare Patient Assistance Program (Cabenuva)

Elligibility requirements:
  1. *Contact program for details.
  2. At or below 500% of FPL
  3. Medically appropriate condition/diagnosis
  4. Must live in US, DC or Puerto Rico
  5. *Contact ViiV Connect for additional information at 844-588-3288 or www.viivconnect.com Medicare Part B, Part D and Medicare Advantage plan patients who need medicine that same day should ask their Patient Representative (ie, anyone involved in the delivery of the patient's healthcare and is not a family member or friend) to enroll them in ViiV Healthcare PAP by phone. Patients enrolled in a Medicare Part B, Part D and Medicare Advantage prescription drug plan must apply via mail or fax and be found eligible before medicine can be shipped.
Applicable drugs:
  • Cabenuva (cabotegravir and rilpivirine) Extended Release Injections for Suspension

More information please phone: 844-588-3288 Visit Website